Abstract
IntroductionEnd stage liver disease (ESLD) negatively impacts muscle homeostasis with observed reductions in muscle mass (sarcopenia) and strength. The current recommended measures of muscle mass in ESLD are 3rd lumbar...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
